content

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to...

World Health Organization Authorizes SINOVACs CoronaVac for Emergency Use

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVacยฎ, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences...

Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called โ€˜cytokine stormโ€™ with its lead drug candidate, lenzilumab,ย  announced...

Biological E to produce Providence Therapeutics mRNA COVID-19 vaccine in India

Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latterโ€™s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India....

Tessol launches cold solutions for vaccine delivery

Tessol has launched a solution for vaccine delivery across India to aid the massive COVID-19 vaccination drive undergoing in the country. The company has...

Engine Biosciences expands its digital drug discovery pipeline with $43M round

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former,...

NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits EUA Application to US FDA to Treat Critical COVID-19 in Patients

NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with U.S. FDA requesting Emergency Use Authorization (EUA) for ZYESAMIโ„ข...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read